glp-1 drugs and hashimoto's Agonists: A Comprehensive Overview Best GLP-1 for Hashimoto's: Safety

Overall, 79% of GLP-1 users said they felt more in control of impulsive behaviors after starting GLP-1s

Real-World Considerations When choosing a GLP-1 medication, doctors and patients must weigh more than just the numbers

For some patients, obesity pharmacotherapy may be a long-term treatment rather than a time-limited intervention

Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H, Diehl AM, Djedjos CS, Han L, Myers RP, Subramanian GM, McHutchison JG, Goodman ZD, Afdhal NH, Charlton MR (2017) The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial